![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, July 21, 2020 2:45:40 PM
I have been consistently surprised with the following:
1. The amount of time that it takes Pluristem to get clinical trials enrolled.
2. The failure to commercialize or move forward on trials with very promising results (hip).
3. The failure of previous partnerships. Still don't know what went wrong or caused the partners to abandon Pluristem.
Having been involved in some studies and a clinical trial I have seen them fill up rapidly.
Any ideas or is the delay to get trials populated something that all others are experiencing?
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM